NovoEight IV 2000 (YJ code: 6343440D5029, 2,000 IU x 1 bottle (with dissolving liquid)), manufactured by Novo Nordisk Pharma, contains Turoctocog alpha (genetically recombination). This recombinant Factor VIII product is used to treat and prevent bleeding episodes, including those occurring during surgery, in people with hemophilia A.
NovoEight IV 2000
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →